Dextenza Insert and Insulin Glargine (U-300) Pens
Determining the interaction of Dextenza Insert and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular)
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextenza Insert-Insulin glargine and lixisenatide
- Dextenza Insert-Insulin glargine and lixisenatide Subcutaneous
- Dextenza Insert-Insulin glargine, recombinant Subcutaneous
- Dextenza Insert-Insulin glulisine
- Dextenza Insert-Insulin Glulisine (Cartridges and Pens)
- Dextenza Insert-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Dextenza intraocular
- Insulin Glargine (U-300) Pens-Dextran 40
- Insulin Glargine (U-300) Pens-Dextran 70 6% in 5% Dextrose high molecular weight
- Insulin Glargine (U-300) Pens-Dextran 75
- Insulin Glargine (U-300) Pens-Dextran high molecular weight
- Insulin Glargine (U-300) Pens-Dextranomer and Hyaluronate Derivatives (Deflux)